Narnolia

Narnolia

Toll Free No: 1800-103-7212

GLENMARK PHARMACEUTICALS LTD.

NSE : GLENMARKBSE : 532296ISIN CODE : INE935A01035Industry : Pharmaceuticals & DrugsHouse : Glenmark
BSE460.60-39.6 (-7.92 %)
PREV CLOSE ( ) 500.20
OPEN PRICE ( ) 495.00
BID PRICE (QTY) 460.60 (46)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 288632
TODAY'S LOW / HIGH ( )457.00 495.00
52 WK LOW / HIGH ( )457 711.55
NSE461.00-38.95 (-7.79 %)
PREV CLOSE( ) 499.95
OPEN PRICE ( ) 495.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 461.00 (8727)
VOLUME 8038743
TODAY'S LOW / HIGH( ) 459.00 495.00
52 WK LOW / HIGH ( )459 711.9
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 18-11 1977
Management Info
Glenn Saldanha - Chairman Glenn Saldanha - Managing Director
Registered Office

Address B/2 Mahalaxmi Chambers,22 Bhulabhai Desai Road, ,
Mumbai,
Maharashtra-400026

Phone

Email webmaster@glenmarkpharma.com

Website www.glenmarkpharma.com

Registrars Details
Karvy Fintech Pvt Ltd.-(Karvy Computuershare Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS
24Jun Glenmark Pharma’s arm signs partnershi
Glenmark Pharmaceuticals’ Brazilian subsidiary -- Glenmark Farmaceutica..
24Jun Glenmark Pharmaceuticals submits media
Glenmark Pharmaceuticals has informed about submission of media release..
24Jun Glenmark Pharma receives complete resp
Glenmark Pharmaceuticals has been issued with Complete Response Letter (..
22Jun Glenmark Pharmaceuticals informs about
Glenmark Pharmaceuticals has informed that the US Food and Drug Administ..
20Jun Glenmark Pharmaceuticals’ arm receives
Glenmark Pharmaceuticals’ subsidiary -- Glenmark Pharmaceuticals Inc., U..
Financials
Rs. in Millions
QTR Mar 19 ANNUAL 19
Net Profit2812.8816221.12
Gross Profit 3581.81 18181.84
Operating Profit 4371.3718030.92
Net Sales 15872.7963048.67
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Sanofi India (BSE)
peergroup  5428.70 (2.06%)
M.Cap ( in Cr)12502.63
Hester Biosciences (BSE)
peergroup  1769.05 (3.75%)
M.Cap ( in Cr)1504.91
Piramal Enterprises (BSE)
peergroup  1945.60 (2.96%)
M.Cap ( in Cr)38687.59
Astrazeneca Pharma I (BSE)
peergroup  1942.35 (2.66%)
M.Cap ( in Cr)4855.88
Abbott India (BSE)
peergroup  8537.20 (0.41%)
M.Cap ( in Cr)18140.95
Shareholding Pattern
PROMOTERS 46.54%
MUTUAL FUNDS/UTI 4.18%
FI/BANKS/INSURANCE 2.57%
NON-INSTITUTION 13.9%
GOVERNMENT 0%
FII 0%
About Glenmark Pharmaceuticals Ltd.

Glenmark Pharmaceuticals Ltd. was incorporated in the year 18-11-1977. Its today's share price is 500.2. Its current market capitalisation stands at Rs 12996.67 Cr. In the latest quarter, company has reported Gross Sales of Rs. 91030.7 Cr and Total Income of Rs.91658.19 Cr. The company's management includes Harish Kuber, VS Mani, Rajesh V Desai, D R Mehta, Milind Sarwate, B E Saldanha, Sridhar Gorthi, Julio F Ribeiro, Bernard Munos, Brian W Tempest, Cherylann Pinto, Glenn Saldanha, Glenn Saldanha.

It is listed on the BSE with a BSE Code of 532296 , NSE with an NSE Symbol of GLENMARK and ISIN of INE935A01035. It's Registered office is at B/2 Mahalaxmi Chambers,22 Bhulabhai Desai Road, Mumbai-400026, Maharashtra. Their Registrars are ACC Ltd. It's auditors are Arthur Andersen & Associates, Price Waterhouse, VK Bahri & Co, Walker Chandiok & Co LLP, Walker, Chandiok & Co, Walker, Chandiok & Co LLP

Directory

Narnolia Research & Advisory Narnolia Trading Platforms Narnolia Online | media Room